DIFICID: targeted therapy for the treatment of Clostridium difficile-associated diarrhea (CDAD)
DIFICID is an antibacterial drug that treats Clostridium difficile (klos-TRID-e-uhm dif-uh-SEEL)-associated diarrhea (CDAD) (pronounced see-dad) in adults 18 years of age and older. DIFICID is a tablet taken by mouth, two times a day for 10 days, with or without food.
DIFICID Commercial Co-Pay Assistance Program
Learn how you may be able to save on your prescription with the DIFICID Commercial Co-Pay Assistance Program
Healthcare Professional Discussion Guide
Download the Healthcare Professional Discussion Guide to help you talk to your healthcare professional about CDAD
Indication and Important Safety Information
- DIFICID® (fidaxomicin) is an antibacterial drug for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age or older
- DIFICID should not be used by patients who are allergic to fidaxomicin (the main ingredient of DIFICID)
Warnings and Precautions
- DIFICID should not be taken for systemic infections (infections that affect multiple organs and/or the body as a whole)
- Serious allergic reactions (swelling under the skin, shortness of breath, itching, and rash) have been reported by patients taking DIFICID. If you have a serious allergic reaction, stop taking DIFICID
- Only take DIFICID for an infection that your healthcare professional has determined is caused by C. difficile. Taking DIFICID when you do not have a C. difficile infection will not provide benefit and can increase the likelihood that bacteria will develop resistance and will not be treatable by DIFICID or other antibacterial drugs in the future
- The most common side effects reported in clinical trials were nausea (11%), vomiting (7%), abdominal pain (6%), bleeding in the gastrointestinal tract (4%), decrease in the number of red blood cells (2%), and a low number of neutrophils (type of white blood cell) (2%)
Please see full Prescribing Information for DIFICID.